Litcius/Paper detail

MA13.07 TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC

B. Levy, L. Paz-Ares, O. Rixe, W.-C. Su, Tianpeng Yang, A. Tolcher, Y. Lou, Y. Zenke, P. Savvides, E. Felip, M. Domine, K. Leventakos, M.P. Pulla, M. Koczywas, A. Horiike, S. Rawat, X. Wu, Puspita Basak, M. Chisamore, Y. Goto

2022Journal of Thoracic Oncology19 citationsDOI

Topics & Concepts

MedicinePembrolizumabOncologyInternal medicineChemotherapyRefractory (planetary science)Expanded accessCancerImmunotherapyPhysicsAstrobiologyLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research Studies
MA13.07 TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC | Litcius